首页> 外文期刊>Disease models & mechanisms: DMM >Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens
【24h】

Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens

机译:患病肝脏的细胞疗法:从干细胞生物学到肝人类病原体的新模型

获取原文
           

摘要

It has long been known that hepatocytes possess the potential to replicate through many cell generations because regeneration can be achieved in rodents after serial two-thirds hepatectomy. It has taken considerable time and effort to harness this potential, with liver regeneration models involving hepatocyte transplantation developing over the past 15 years. This review will describe the experiments that have established the models and methodology for liver repopulation, and the use of cells other than adult hepatocytes in liver repopulation, including hepatic cell lines and hematopoietic, cord blood, hepatic and embryonic stem cells. Emphasis will be placed on the characteristics of the models and how they can influence the outcome of the experiments. Finally, an account of the development of murine models that are competent to accept human hepatocytes is provided. In these models, liver deficiencies are induced in immunodeficient mice, where healthy human cells have a selective advantage. These mice with humanized livers provide a powerful new experimental tool for the study of human hepatotropic pathogens.
机译:早就知道,肝细胞具有在许多细胞世代中复制的潜力,因为可以在连续三分之二的肝切除术后在啮齿动物中实现再生。在过去的15年中,涉及肝细胞移植的肝再生模型不断发展,已经花费了大量的时间和精力来发挥这种潜力。这篇综述将描述建立肝再造模型和方法的实验,以及在肝再造中使用成年肝细胞以外的细胞,包括肝细胞系和造血,脐带血,肝和胚胎干细胞。重点将放在模型的特征以及它们如何影响实验结果上。最后,提供了能够接受人类肝细胞的鼠模型的发展的说明。在这些模型中,免疫缺陷小鼠会诱发肝功能不全,健康的人细胞具有选择性优势。这些具有人源化肝脏的小鼠为研究人类肝脏病原体提供了强大的新实验工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号